Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
Status:
Not yet recruiting
Trial end date:
2030-07-01
Target enrollment:
Participant gender:
Summary
This is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in
patients with incurable non-small cell lung cancer. Participants in both arms will be
receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard
care. We plan to enroll 90 patients over 5 years.